Substance with protein-tyrosine kinase inhibitor mechanism of action (substance)
| Code | 372917005 |
|---|---|
| Semantic tag | substance |
| Module | international |
| Definition | defined |
| Effective time | 20180131 |
426265004Protein kinase inhibitor
substance
703579002Afatinib
substance
703582007Afatinib dimaleate
substance
716039000Alectinib
substance
716040003Alectinib hydrochloride
substance
40585411000001108Asciminib
substance
40585311000001101Asciminib hydrochloride
substance
838462005Avapritinib
substance
427882000Axitinib
substance
703128001Bosutinib
substance
607951000202108Bosutinib dihydrate
substance
703585009Bosutinib monohydrate
substance
736634002Brigatinib
substance
718844003Cabozantinib
substance
703146007Ceritinib
substance
715257001Cobimetinib
substance
734511001Cobimetinib hemifumarate
substance
703637000Crizotinib
substance
781492009Dacomitinib
substance
1268999006Dacomitinib anhydrous
substance
1155971003Dacomitinib monohydrate
substance
423658008Dasatinib
substance
61821000087109Dasatinib (S)-propylene glycol
substance
1269003005Dasatinib anhydrous
substance
789356007Entrectinib
substance
787731007Erdafitinib
substance
414123001Erlotinib
substance
426686007Erlotinib hydrochloride
substance
772033003Fostamatinib
substance
239391000087103Fostamatinib disodium
substance
38703111000001101Fostamatinib disodium hexahydrate
substance
1363353001Fruquintinib
substance
407100002Gefitinib
substance
782974005Gilteritinib
substance
414460008Imatinib
substance
129558005Imatinib mesilate
substance
704312008Janus kinase inhibitor
substance
425820005Lapatinib
substance
426238006Lapatinib ditosylate
substance
1269168000Lapatinib ditosylate anhydrous
substance
725960003Lapatinib ditosylate monohydrate
substance
782977003Larotrectinib
substance
579861000202108Lazertinib mesilate monohydrate
substance
1373927003Lazertinib mesylate
substance
714108002Lenvatinib
substance
735068004Lenvatinib mesilate
substance
782976007Lorlatinib
substance
1162753006Mesenchymal epithelial transition inhibitor
substance
763613005Midostaurin
substance
40609711000001106Mobocertinib
substance
40618011000001101Mobocertinib succinate
substance
736632003Neratinib
substance
736633008Neratinib maleate
substance
427941004Nilotinib
substance
783273004Nilotinib hydrochloride
substance
1269148006Nilotinib hydrochloride anhydrous
substance
438943005Nilotinib hydrochloride monohydrate
substance
443763005Pazopanib
substance
735169009Pazopanib hydrochloride
substance
871699001Pemigatinib
substance
789180004Pexidartinib
substance
703796003Ponatinib
substance
703797007Ponatinib hydrochloride
substance
926312002Pralsetinib
substance
42444811000001104Quizartinib
substance
42444711000001107Quizartinib dihydrochloride
substance
702804006Regorafenib
substance
933536591000036100Repotrectinib
substance
781256007Rho-associated protein kinase inhibitor
substance
876860008Ripretinib
substance
876841001Selpercatinib
substance
422042001Sorafenib
substance
432886002Sorafenib tosylate
substance
710227007Substance with non-specific protein-tyrosine kinase inhibitor mechanism of action
substance
421192001Sunitinib
substance
426455008Sunitinib malate
substance
1144610005Tirbanibulin
substance
738747006Tivozanib
substance
1179089005Tivozanib hydrochloride
substance
1269090003Tivozanib hydrochloride anhydrous
substance
449278009Toceranib
substance
449541005Toceranib phosphate
substance
871698009Tucatinib
substance
418260004Vandetanib
substance